Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
BMC Women'S Health|July 11, 2026
Ectocervical margin involvement is associated with postoperative hrHPV positivity after hysterectomy or residual cervix resection for incompletely excised CIN3: a retrospective studyYedan Ren, Xiuli Zhang, Junfen Xu
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 4, 2021
Ovarian Metastasis by Gastric-type Endocervical Adenocarcinoma: A Clinicopathologic Description of 12 CasesBingjian Lu, Haiyan Shi, Ying Shao, et al.
Clinical and Translational Medicine|November 23, 2025
Single-cell landscape of the tumour immune microenvironment in human gynaecologic malignanciesSimin Yin, Sen Li, Mengyan Tu, et al.
Scientific Reports|October 7, 2020
Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinomaJunfen Xu, Jian Zou, Luyao Wu, et al.
Cancer Management and Research|December 18, 2018
miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancerYifeng Fang, Xiao Liang, Junfen Xu, et al.
Cancer Medicine|December 31, 2025
A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine CarcinomaYedan Ren, Sen Li, Simin Xiang, et al.
World Journal of Surgical Oncology|January 4, 2025
Clinicopathological and prognostic factor analyses of primary fallopian tube carcinoma and high-grade serous ovarian cancer: a single-institution retrospective studyMengyan Tu, Xueyan Gao, Tianchen Guo, et al.
Journal of Gynecologic Oncology|November 9, 2023
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled studyTingting Chen, Junfen Xu, Bairong Xia, et al.
Journal of Gynecologic Oncology|June 20, 2025
A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinomaYixuan Cen, Mengyan Tu, Yanan Zhang, et al.
Frontiers in Medicine|April 4, 2022
Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers ExperiencesYuanming Shen, Sangsang Tang, Junfen Xu, et al.
Pageof 8